Piracetam EP Impurity C

Piracetam EP Impurity C
Product Description

Impurity in commercial preparation of Piracetam.

CLEARSYNTH LABS LIMITED

  • IN
  • 2015
    On CPHI since
  • 2
    Certificates
  • 250 - 499
    Employees
Company types
CMO/CDMO
Manufacturer/Innovator
Primary activities
Agrochemical
Analytical Services
Biopharmaceutical
Clinical Research
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
Fine Chemicals Company
Intermediates Manufacturer
Pharmacy
Specifications
  • CAS Registry Number
    61516-73-2

CLEARSYNTH LABS LIMITED

  • IN
  • 2015
    On CPHI since
  • 2
    Certificates
  • 250 - 499
    Employees
Company types
CMO/CDMO
Manufacturer/Innovator
Primary activities
Agrochemical
Analytical Services
Biopharmaceutical
Clinical Research
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
Fine Chemicals Company
Intermediates Manufacturer
Pharmacy

More Products from CLEARSYNTH LABS LIMITED (99)

  • Clopidogrel D3 Hydrochloride

    Product Clopidogrel D3 Hydrochloride

    Labeled Clopidogrel, intended for use as an internal standard for the quantification of Clopidogrel by GC- or LC-mass spectrometry.
  • Clopidogrel D3 Hydrogen sulphate

    Product Clopidogrel D3 Hydrogen sulphate

    Labeled Clopidogrel, intended for use as an internal standard for the quantification of Clopidogrel by GC- or LC-mass spectrometry.
  • Diazepam Impurity F (BP)

    Product Diazepam Impurity F (BP)

    Impurity in commercial preparations of Diazepam
  • Doxofylline

    Product Doxofylline

    Doxofylline is a xanthine molecule that appears to be both bronchodilator and anti-inflammatory with an improved therapeutic window over conventional xanthines such as Theophylline and the evidence supporting the effects of Doxofylline in the treatment
  • Rasagiline

    Product Rasagiline

    Rasagiline, is a selective and irreversible propargylamine inhibitor of monoamine oxidase which has been used to increase the availability of dopamine at striatal receptors as a method to treat Parkinson’s disease.
  • Papaverine

    Product Papaverine

    Molecular formula: C20H22ClNO4Molecular weight: 339.38
  • Rilpivirine D6

    Product Rilpivirine D6

    Labeled Rilpivirine, intended for use as an internal standard for the quantification of Rilpivirine by GC- or LC-mass spectrometry.
  • Sildenafil D3

    Product Sildenafil D3

    Labeled Sildenafil, intended for use as an internal standard for the quantification of Sildenafil by GC- or LC-mass spectrometry.
  • Sumatriptan

    Product Sumatriptan

    Molecular formula: C14H21N3O2SMolecular weight: 295.14
  • Dexlansoprazole

    Product Dexlansoprazole

    Molecular formula: C16H14F3N3O2SMolecular weight: 369.36
  • Diatrizoic acid

    Product Diatrizoic acid

    Molecular formula: C11H9I3N2O4Molecular weight: 613.91
  • Dipyridamole D20

    Product Dipyridamole D20

    Selective inhibitor of phosphodiesterase V (PDE 5); potent coronary vasodilator drug; adenosine transport inhibitor; inhibitor of platelet aggregation.;Labeled Dipyridamole, intended for use as an internal standard for the quantification of Dipyridamole by GC- or LC-mass spectrometry.

CLEARSYNTH LABS LIMITED resources (1)